Re: Zenith Epigenetics Advances ZEN-3694 in Multiple Cancer Programs

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

narmac

Rank: Vice President [?]

Points: 3989 [?]

Votes: 36 Score: 3.0 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Zenith Epigenetics Advances ZEN-3694 in Multiple Cancer Programs

in response to

Zenith Epigenetics Advances ZEN-3694 in Multiple Cancer Programs

BearDownAZ

posted on Jul 29, 2020 03:22PM

"Merck, Pfizer, UCSF and Newsoara"

Since we started rubbing elbows with these big boys one would think we nor Resverlogix are NOT flying under anyones radar these days!!!

It should be assumed ,,future partners will be probably one or more of these names! JMO

7 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply